In Brazil, malaria still remains a clinically important febrile syndrome for local populations and travelers, occurring mostly in the Amazon Basin. This review aims to report the main efforts employed to control this disease since the 1940s and the emergence of Plasmodium falciparum and Plasmodium vivax chemoresistance to chloroquine and sulphadoxine-pyrimethamine among other drugs. Additionally, in vivo, in vitro and molecular studies as well as malaria chemoresistance consequences on disease morbidity and policy treatment guidelines were commented.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s0074-02762011000900020 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!